tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ATNM is currently covered by 1 analysts with an average price target of $5. This is a potential upside of $6.64 (346.43%) from yesterday's end of day stock price of $1.12.
Actinium Pharmaceuticals's activity chart (see below) currently has 35 price targets and 42 ratings on display. The stock rating distribution of ATNM is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 1.33% with an average time for these price targets to be met of 304.6 days.
Highest price target for ATNM is $5, Lowest price target is $5, average price target is $5.
Most recent stock forecast was given by SUDAN LOGANATHAN from STEPHENS on 31-Mar-2026. First documented stock forecast 04-Jun-2020.
Currently out of the existing stock ratings of ATNM, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-May-2024
$5
$3.96 (380.77%)
$5
Buy Since 04-Jun-2020
$4
$2.96 (284.62%)
$4
Buy Since 08-Sep-2022
$21
$19.96 (1919.23%)
$21
Buy Since 25-Aug-2022
$16
$14.92 (1381.48%)
$20
What is ATNM (Actinium Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ATNM (Actinium Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ATNM (Actinium Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ATNM (Actinium Pharmaceuticals)?
Which analyst is the currently most bullish on ATNM (Actinium Pharmaceuticals)?
Which analyst is the currently most reserved on ATNM (Actinium Pharmaceuticals)?
